Anti-inflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway

International Immunopharmacology

Volumn 25, Issue 1, 2015, Pages 189-198

  Funakoshi Tago, Megumi ^a   Okamoto, Kazuhi ^a   Izumi, Rika ^a   Tago, Kenji ^b   Yanagisawa, Ken ^b   Narukawa, Yuji ^a   Kiuchi, Fumiyuki ^a   Kasahara, Tadashi ^a   Tamura, Hiroomi ^a  

^a KEIO UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti inflammatory activity; Flavonoid; IKK; IL 33; NF kB; Propolis

Indexed keywords

3',4' DIHYDROXY 4 METHOXYDALBERGIONE; 4 METHOXYDALBERGION; 7 HYDROXY FLAVANONE; CEAROIN; CHRYSIN; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 6; ISOLIQUIRITIGENIN; MEDICARPIN; MESSENGER RNA; PLATHYMENIN; PROPOLIS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; CYTOKINE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW DERIVED MAST CELL; CELL NUCLEUS; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; BONE MARROW CELL; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MAST CELL; METABOLISM; TRANSCRIPTION INITIATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BONE MARROW CELLS; CELLS, CULTURED; CYTOKINES; FLAVONOIDS; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INTERLEUKIN-33; MAST CELLS; MICE; NF-KAPPA B; PROPOLIS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84922568635     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.01.012     Document Type: Article

References (47)

1. W.P. Arend, G. Palmer, and C. Gabay IL-1, IL-18, and IL-33 families of cytokines Immunol Rev 223 2008 20 38
2. Y. Kondo, T. Yoshimoto, K. Yasuda, S. Futatsugi-Yumikura, M. Morimoto, and N. Hayashi Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system Int Immunol 20 2008 791 800
3. Y. Haenuki, K. Matsushita, S. Futatsugi-Yumikura, K.J. Ishii, T. Kawagoe, and Y. Imoto A critical role of IL-33 in experimental allergic rhinitis J Allergy Clin Immunol 130 2012 184 194
4. S. Matsuba-Kitamura, T. Yoshimoto, K. Yasuda, S. Futatsugi-Yumikura, Y. Taki, and T. Muto Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis Int Immunol 22 2010 479 489
5. C.J. Beltrán, L.E. Núñez, D. Díaz-Jiménez, N. Farfan, E. Candia, and C. Heine Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease Inflamm Bowel Dis 16 2010 1097 1107
6. T. Savinko, S. Matikainen, U. Saarialho-Kere, M. Lehto, G. Wang, and S. Lehtimäki IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors J Invest Dermatol 132 2012 1392 1400
7. Y. Imai, K. Yasuda, Y. Sakaguchi, T. Haneda, H. Mizutani, and T. Yoshimoto Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice Proc Natl Acad Sci U S A 110 2013 13921 13926
8. M. Fux, T. Pecaric-Petkovic, A. Odermatt, O.V. Hausmann, A. Lorentz, and S.C. Bischoff IL-33 is a mediator rather than a trigger of the acute allergic response in humans Allergy 69 2014 216 222
9. K. Yanaba, A. Yoshizaki, Y. Asano, T. Kadono, and S. Sato Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis Clin Rheumatol 30 2011 825 830
10. L. Pastorelli, R.R. Garg, S.B. Hoang, L. Spina, B. Mattioli, and M. Scarpa Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis Proc Natl Acad Sci U S A 107 2010 8017 8022
11. J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy, and T.K. McClanahan IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
12. D. Kempuraj, E.C. Twait, D.E. Williard, Z. Yuan, D.K. Meyerholz, and I. Samuel The novel cytokine interleukin-33 activates acinar cell proinflammatory pathways and induces acute pancreatic inflammation in mice PLoS One 8 2013 e56866
13. D. Moulin, O. Donzé, D. Talabot-Ayer, F. Mézin, G. Palmer, and C. Gabay Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells Cytokine 40 2007 216 225
14. I.S. Junttila, C. Watson, L. Kummola, X. Chen, J. Hu-Li, and L. Guo Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3 J Allergy Clin Immunol 132 2013 704 712
15. M. Komai-Koma, F. Brombacher, P.N. Pushparaj, B. Arendse, C. McSharry, and J. Alexander Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice Allergy 67 2012 1118 1126
16. S. Ali, M. Huber, C. Kollewe, S.C. Bischoff, W. Falk, and M.U. Martin IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells Proc Natl Acad Sci U S A 104 2007 18660 18665
17. A. Lingel, T.M. Weiss, M. Niebuhr, B. Pan, B.A. Appleton, and C. Wiesmann Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors - insight into heterotrimeric IL-1 signaling complexes Structure 17 2009 1398 1410
18. K.M. Kroeger, B.M. Sullivan, and R.M. Locksley IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway J Leukoc Biol 86 2009 769 778
19. M. Funakoshi-Tago, K. Tago, M. Hayakawa, S. Tominaga, T. Ohshio, and Y. Sonoda TRAF6 is a critical signal transducer in IL-33 signaling pathway Cell Signal 20 2008 1679 1686
20. E. Zandi, D.M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation Cell 91 1997 243 252
21. F. Mercurio, H. Zhu, B.W. Murray, A. Shevchenko, B.L. Bennett, and J. Li IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation Science 278 1997 860 866
22. J.D. Woronicz, X. Gao, Z. Cao, M. Rothe, and D.V. Goeddel IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK Science 278 1997 866 869
23. J.H. de Farias, A.S. Reis, M.A. Araújo, M.J. Araújo, A.K. Assunção, and J.C. de Farias Effects of stingless bee propolis on experimental asthma Evid Based Complement Altern Med 2014 2014 951478
24. K.G. Neiva, D.L. Catalfamo, S. Holliday, S.M. Wallet, and R. Pileggi Propolis decreases lipopolysaccharide-induced inflammatory mediators in pulp cells and osteoclasts Dent Traumatol 30 2014 362 367
25. J.M. Sforcin, and V. Bankova Propolis: is there a potential for the development of new drugs? J Ethnopharmacol 133 2011 253 260
26. S.P. Shrestha, Y. Narukawa, and T. Takeda Chemical constituents of Nepalese propolis: isolation of new dalbergiones and related compounds J Nat Med 61 2007 73 76
27. S.P. Shrestha, Y. Narukawa, and T. Takeda Chemical constituents of Nepalese propolis (II) Chem Pharm Bull (Tokyo) 55 2007 926 929
28. F.X. Zhang, C.J. Kirschning, R. Mancinelli, X.P. Xu, Y. Jin, and E. Faure Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes J Biol Chem 274 1999 7611 7614
29. E. Razin, J.M. Mencia-Huerta, R.A. Lewis, E.J. Corey, and K.F. Austen Generation o leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow Proc Natl Acad Sci U S A 79 1982 4665 4667
30. M. Funakoshi-Tago, T. Shimizu, K. Tago, M. Nakamura, H. Itoh, and Y. Sonoda Celecoxib potently inhibits TNFalpha-induced nuclear translocation and activation of NF-kappaB Biochem Pharmacol 76 2008 662 671
31. M. Funakoshi-Tago, S. Tanabe, K. Tago, H. Itoh, T. Mashino, and Y. Sonoda Licochalcone A potently inhibits tumor necrosis factor alpha-induced nuclear factor-kappaB activation through the direct inhibition of IkappaB kinase complex activation Mol Pharmacol 76 2009 745 753
32. A. Ariga, J. Namekawa, N. Matsumoto, J. Inoue, and K. Umezawa Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin J Biol Chem 277 2002 24625 24630
33. J.F. Campos, U.P. dos Santos, L.F. Macorini, A.M. de Melo, J.B. Balestieri, and E.J. Paredes-Gamero Antimicrobial, antioxidant and cytotoxic activities of propolis from Melipona orbignyi (Hymenoptera, Apidae) Food Chem Toxicol 65 2014 374 380
34. D. Teerasripreecha, P. Phuwapraisirisan, S. Puthong, K. Kimura, M. Okuyama, and H. Mori In vitro antiproliferative/cytotoxic activity on cancer cell lines of a cardanol and a cardol enriched from Thai Apis mellifera propolis BMC Complement Altern Med 12 2012 27
35. W.H. Dokter, L. Tuyt, S.J. Sierdsema, M.T. Esselink, and E. Vellenga The spontaneous expression of interleukin-1 beta and interleukin-6 is associated with spontaneous expression of AP-1 and NF-kappa B transcription factor in acute myeloblastic leukemia cells Leukemia 9 1995 425 432
36. A.N. McKenzie, X. Li, D.A. Largaespada, A. Sato, A. Kaneda, and S.M. Zurawski Structural comparison and chromosomal localization of the human and mouse IL-13 genes J Immunol 150 1993 5436 5444
37. R. Beyaert, A. Cuenda, W. Vanden Berghe, S. Plaisance, J.C. Lee, and G. Haegeman The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor EMBO J 15 1996 1914 1923
38. J. Furusawa, K. Moro, Y. Motomura, K. Okamoto, J. Zhu, and H. Takayanagi Critical role of p38 and GATA3 in natural helper cell function J Immunol 191 2013 1818 1826
39. R. Nakamura, R. Nakamura, K. Watanabe, K. Oka, S. Ohta, and S. Mishima Effects of propolis from different areas on mast cell degranulation and identification of the effective components in propolis Int Immunopharmacol 10 2010 1107 1112
40. F.L. Pearce, A.D. Befus, and J. Bienenstock Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells J Allergy Clin Immunol 73 1984 819 823
41. Y. Bae, S. Lee, and S.H. Kim Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-κB Toxicol Appl Pharmacol 254 2011 56 64
42. X. Li, Q. Huang, C.N. Ong, X.F. Yang, and H.M. Shen Chrysin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB Cancer Lett 293 2010 109 116
43. N.G. Amado, D.M. Cerqueira, F.S. Menezes, J.F. da Silva, V.M. Neto, and J.G. Abreu Isoquercitrin isolated from Hyptis fasciculata reduces glioblastoma cell proliferation and changes beta-catenin cellular localization Anticancer Drugs 20 2009 543 552
44. J. Rodriguez, J. Yanez, V. Vicente, M. Alcaraz, O. Benavente-Garcia, and J. Castillo Effects of several flavonoids on the growth of B16F10 and SK-MEL-1 melanoma cell lines: relationship between structure and activity Melanoma Res 12 2002 99 107
45. P.A. Ragazzon, T. Bradshaw, C. Matthews, J. Iley, and S. Missailidis The characterisation of flavone-DNA isoform interactions as a basis for anticancer drug development Anticancer Res 29 2009 2273 2283
46. N.Z. Mamadalieva, F. Herrmann, M.Z. El-Readi, A. Tahrani, R. Hamoud, and D.R. Egamberdieva Flavonoids in Scutellaria immaculata and S. ramosissima (Lamiaceae) and their biological activity J Pharm Pharmacol 63 2011 1346 1357
47. M. Ben Sghaier, I. Skandrani, N. Nasr, M.G. Franca, L. Chekir-Ghedira, and K. Ghedira Flavonoids and sesquiterpenes from Tecurium ramosissimum promote antiproliferation of human cancer cells and enhance antioxidant activity: a structure-activity relationship study Environ Toxicol Pharmacol 32 2011 336 348